EXSIRA Canadian Trademark Information
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the central nervous system and neurological disorders, namely depression, major depressive disorder, anxiety and social anxiety disorder, vasomotor symptoms of menopause, anxiety disorders, neuropathic pain, fibromyalgia, urinary disorders, chronic pain, and functional somatic syndromes. Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the central nervous system and neurological disorders, namely depression, major depressive disorder, anxiety and social anxiety disorder, vasomotor symptoms of menopause, anxiety disorders, neuropathic pain, fibromyalgia, urinary disorders, chronic pain, and functional somatic syndromes.
Perfect for these industries
Words that describe this mark
pharmaceutical preparations prevention treatment diseases disorders central nervous neurological disorders depression major depressive disorder anxiety social anxiety disorder vasomotor symptoms menopause anxiety disorders neuropathic pain fibromyalgia urinary disorders
Abandonment Notice!
On Tuesday, November 13, 2007,
status on the EXSIRA
trademark changed to Application withdrawn.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Wednesday, April 6, 2005, a canadian trademark registration was filed for
EXSIRA by Wyeth *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1253214.
The current status of this trademark filing is Application withdrawn.
The EXSIRA
trademark is filed in the description of
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the central nervous system and neurological disorders, namely depression, major depressive disorder, anxiety and social anxiety disorder, vasomotor symptoms of menopause, anxiety disorders, neuropathic pain, fibromyalgia, urinary disorders, chronic pain, and functional somatic syndromes.
,
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the central nervous system and neurological disorders, namely depression, major depressive disorder, anxiety and social anxiety disorder, vasomotor symptoms of menopause, anxiety disorders, neuropathic pain, fibromyalgia, urinary disorders, chronic pain, and functional somatic syndromes.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.